dc.creatorSilva dos Santos
dc.creatorPriscilla de Nazare; de Souza
dc.creatorAglecio Luiz; Batista
dc.creatorGisele Almeida; Melhado-Kimura
dc.creatorVaneska; de Lima
dc.creatorGabriel Araujo; Bahamondes
dc.creatorLuis; Fernandes
dc.creatorArlete
dc.date2016
dc.datenov
dc.date2017-11-13T13:16:56Z
dc.date2017-11-13T13:16:56Z
dc.date.accessioned2018-03-29T05:53:58Z
dc.date.available2018-03-29T05:53:58Z
dc.identifierArchives Of Gynecology And Obstetrics. Springer Heidelberg, v. 294, p. 1331 - 1336, 2016.
dc.identifier0932-0067
dc.identifier1432-0711
dc.identifierWOS:000386606600031
dc.identifier10.1007/s00404-016-4192-9
dc.identifierhttps://link-springer-com.ez88.periodicos.capes.gov.br/article/10.1007%2Fs00404-016-4192-9
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/327604
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1364629
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionWeight gain has been cited by women as one of the main reasons for discontinuation of the contraceptive depot medroxyprogesterone acetate (DMPA). This study aimed to evaluate binge eating and the biochemical markers of appetite in new DMPA users. In this prospective non randomized study with adult healthy women, twenty-eight users of DMPA and twenty-five users of a copper intrauterine device (IUD) were paired for age (+/- 1 year) and body mass index (BMI) (+/- 1 kg/m(2)). We evaluated binge eating using the Binge Eating Scale (BES), the serum levels of neuropeptide Y, leptin and adiponectin, and the BMI at baseline and after 12 months in both groups. For statistical analysis was used ANOVA for to compare the means of the repeated measurements. Mean age was 29.6 and 28.6 years and BMI was 23.9 and 24.5 kg/m(2) for the DMPA and IUD groups, respectively. After 12 months, the frequency of the scores of binge eating remained low in both groups. There were no significant differences between the groups at 12 months with respect to BMI, levels of NPY, leptin, adiponectin, and BES scores. Healthy adult women did not present with central stimulation of appetite or binge eating disorder in their first year after starting use of DMPA. This study reinforces the use of the contraceptive DPMA and the need for guidance related to living a healthy lifestyle for women who attribute the increase of body weight to the use of the method.
dc.description294
dc.description6
dc.description1331
dc.description1336
dc.descriptionSao Paulo Research Foundation (FAPESP) [2011/14827-9]
dc.descriptionCAPES (Coordination for the Improvement of Higher Education Personnel) through a Grant conceded to PNSS
dc.descriptionBrazilian National Research Council (CNPq)
dc.descriptionFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
dc.descriptionSecretaria de Estado da Saude de Sao Paulo (SES-SP), Brazil [PPSUS/2009, 2009/53293-0]
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.languageEnglish
dc.publisherSpringer Heidelberg
dc.publisherHeidelberg
dc.relationArchives of Gynecology and Obstetrics
dc.rightsfechado
dc.sourceWOS
dc.subjectDepot Medroxyprogesterone Acetate
dc.subjectContraception
dc.subjectNpy
dc.subjectAppetite
dc.subjectEating Disorder
dc.titleBinge Eating And Biochemical Markers Of Appetite In New Users Of The Contraceptive Depot Medroxyprogesterone Acetate
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución